New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
23rd March 2023
Spain: The Chamber of Deputies Agriculture Committee has voted in favour of a proposal to regulate hemp, introduced by the left-wing Podemos, the Catalan ERC and the basque Bildu party, and supported by the ruling Socialists, press reports. The non-law proposal is a request to the government to introduce a bill to provide legal clarity over the production, marketing and consumption of products derived from industrial hemp with less than 1% THC. It is unknown whether the government will act to address the present lack of specific regulation in Spain on CBD and hemp-derived products.
21st March 2023
Spain: A proposal for hemp regulation put forward by the left-wing Podemos party, along with the Catalan ERC and the Basque party Bildu, will be discussed tomorrow by the Chamber of Deputies Agriculture Committee, press reports. It aims to give legal clarity on the production, marketing and consumption of products derived from industrial hemp containing less than 1% THC. The proposal is not a bill but a request to the government to take action and introduce a bill on the subject. There is currently no specific regulation in Spain on hemp-derived or CBD products – indeed, the official interpretation is that CBD products cannot generally be sold. The parties behind the hemp proposal have also asked the Spanish Agency of Medicines and Medical Products (AEMPS) to change this interpretation in line with the Court of Justice of the EU’s ruling in the Kanavape case.
1st March 2023
Spain: Spain is set to quadruple its production of medical cannabis this year, media reports. The Spanish Medicines and Medical Products Agency (AEMPS) forecasts that 23.43 tons of medicinal cannabis will be produced in the country in 2023, placing it among the world’s top 11 producers. The sale and consumption of cannabis is still not regulated in Spain, despite government promises to introduce regulation by January, as demanded by the parliamentary Subcommittee on Medical Cannabis.
22nd February 2023
Spain: The Chamber of Deputies yesterday rejected by 261 votes to 78 a bill on both medical and recreational cannabis introduced by the Republican Left of Catalonia (ERC) party. The proposal was supported by the Unidas Podemos party but was voted down by the co-ruling Socialist Party, the centre-right Partido Popular and the right-wing Vox. It would have allowed access to medical cannabis under prescription, and the consumption of cannabis anywhere tobacco smoking is allowed.
20th February 2023
27th January 2023
20th January 2023
19th January 2023
Spain: The president of the Spanish Observatory on Medical Cannabis has criticised the lack of regulation of medical cannabis in Spain, press reports. Carola Pérez said that while 21 companies are authorised to grow and manufacture medical cannabis, it cannot be sold in the country but must be exported. The Spanish Agency for Medicines and Health Products (AEMPS), which comes under the Ministry of Health, should have had the regulation on medical cannabis ready by 27th December, following the six-month deadline set by the Subcommittee on Medical Cannabis.
12th January 2023
Spain: The centre party Ciudadanos has denounced the government’s failure to bring in promised regulation of medical cannabis and called on it to do so, press reports. The Spanish Agency for Medicines and Health Products (AEMPS), which comes under the Ministry of Health, should have had regulation ready by 27th December, following the six-month deadline set by the Subcommittee on Medical Cannabis. Now they say it will be introduced in the next few months.
9th January 2023
24th November 2022
Spain: The Ministry of Health has confirmed in answer to a parliamentary question, which was published on Monday, that the Spanish Agency for Medicines and Health Products (AEMPS) could have the medical cannabis regulation ready by next month, meeting the six-month deadline set by the Subcommittee on Medical Cannabis. The regulation will allow the medical use of cannabis for patients suffering from epilepsy or from cancer-related pain.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.